PLA2G4A and breast carcinoma: Firstly, we analyzed the clinical significance of S100A7 and cPLA2 (PLA2G4A) in invasive breast cancer using publically available breast cancer datasets and human breast cancer tissue microarray (TMAs) by immunohistochemistry analysis.